Join 120+ Members Calling for a Bipartisan Legislative Fix for TPS

There is increasing concern among immigrant communities throughout the United States about their future in this country. Among those living in fear are
people who are in receipt of Temporary Protected Status (TPS) or Deferred Enforced Departure (DED). Fear has grown exponentially given the way the Trump Administration has handled the TPS program. Since the President took office, his Administration has ended
TPS for Sudan; Nicaragua; Haiti; El
Salvador; Nepal and Honduras. The terminations affect 98%
of the total number of immigrants offered protections under TPS. The President has also decided to end the DED program
for Liberians.

Read More

Co-sponsor the bipartisan LIVER Act – Support robust research and funding for liver cancer and liver illness initiatives

In 2018, approximately 42,220 people in the United States will be diagnosed with primary liver cancer, and approximately 30,200 will die from the disease because it is rarely detected sufficiently early for successful treatment.[1]
The five-year survival rate of 18 percent makes liver cancer one of the deadliest forms of cancer,[2] and though the overall cancer death rate has decreased recently, the liver cancer death rate is on the rise.[3]
Furthermore, early detection is key towards a higher survival rate. When diagnosed in the early stages, liver cancer has a five-year survival rate of 31 percent,[4] but shrinks drastically to only 3 percent when
liver cancer is diagnosed in the later stages.[5]

Read More

Co-sponsor the bipartisan LIVER Act – Support robust research and funding for liver cancer and liver illness initiatives

In 2018, approximately 42,220 people in the United States will be diagnosed with primary liver cancer, and approximately 30,200 will die from the disease because it is rarely detected sufficiently early for successful treatment.[1]
The five-year survival rate of 18 percent makes liver cancer one of the deadliest forms of cancer,[2] and though the overall cancer death rate has decreased recently, the liver cancer death rate is on the rise.[3]
Furthermore, early detection is key towards a higher survival rate. When diagnosed in the early stages, liver cancer has a five-year survival rate of 31 percent,[4] but shrinks drastically to only 3 percent when
liver cancer is diagnosed in the later stages.[5]

Read More

Closing today: Co-sponsor the bipartisan LIVER Act – Support robust research and funding for liver cancer and liver illness initiatives

In 2018, approximately 42,220 people in the United States will be diagnosed with primary liver cancer, and approximately 30,200 will die from the disease because it is rarely detected sufficiently early for successful treatment.[1]
The five-year survival rate of 18 percent makes liver cancer one of the deadliest forms of cancer,[2] and though the overall cancer death rate has decreased recently, the liver cancer death rate is on the rise.[3]
Furthermore, early detection is key towards a higher survival rate. When diagnosed in the early stages, liver cancer has a five-year survival rate of 31 percent,[4] but shrinks drastically to only 3 percent when
liver cancer is diagnosed in the later stages.[5]

Read More

Closing today: Co-sponsor the bipartisan LIVER Act – Support robust research and funding for liver cancer and liver illness initiatives

In 2018, approximately 42,220 people in the United States will be diagnosed with primary liver cancer, and approximately 30,200 will die from the disease because it is rarely detected sufficiently early for successful treatment.[1]
The five-year survival rate of 18 percent makes liver cancer one of the deadliest forms of cancer,[2] and though the overall cancer death rate has decreased recently, the liver cancer death rate is on the rise.[3]
Furthermore, early detection is key towards a higher survival rate. When diagnosed in the early stages, liver cancer has a five-year survival rate of 31 percent,[4] but shrinks drastically to only 3 percent when
liver cancer is diagnosed in the later stages.[5]

Read More

Closing Thursday: Call for original co-sponsors on the bipartisan LIVER Act – Support robust research and funding for liver cancer and liver illness initiatives

In 2018, approximately 42,220 people in the United States will be diagnosed with primary liver cancer, and approximately 30,200 will die from the disease because it is rarely detected sufficiently early for successful treatment.[1]
The five-year survival rate of 18 percent makes liver cancer one of the deadliest forms of cancer,[2] and though the overall cancer death rate has decreased recently, the liver cancer death rate is on the rise.[3]
Furthermore, early detection is key towards a higher survival rate. When diagnosed in the early stages, liver cancer has a five-year survival rate of 31 percent,[4] but shrinks drastically to only 3 percent when
liver cancer is diagnosed in the later stages.[5]

Read More

Closing Thursday: Call for original co-sponsors on the bipartisan LIVER Act – Support robust research and funding for liver cancer and liver illness initiatives

In 2018, approximately 42,220 people in the United States will be diagnosed with primary liver cancer, and approximately 30,200 will die from the disease because it is rarely detected sufficiently early for successful treatment.[1]
The five-year survival rate of 18 percent makes liver cancer one of the deadliest forms of cancer,[2] and though the overall cancer death rate has decreased recently, the liver cancer death rate is on the rise.[3]
Furthermore, early detection is key towards a higher survival rate. When diagnosed in the early stages, liver cancer has a five-year survival rate of 31 percent,[4] but shrinks drastically to only 3 percent when
liver cancer is diagnosed in the later stages.[5]

Read More